Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders

MLL-Rearranged B Lymphoblastic Leukemias Selectively Express the Immunoregulatory Carbohydrate-Binding Protein Galectin-1

(2010) P. Juszczynski et al.   CLINICAL CANCER RESEARCH

Anti–CTLA-4 Antibody Therapy: Immune Monitoring During Clinical Development of a Novel Immunotherapy

(2010) Margaret K. Callahan et al.   SEMINARS IN ONCOLOGY

How I treat EBV lymphoproliferation

(2009) H. E. Heslop   BLOOD

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10

(2009) Juan M Ilarregui et al.   NATURE IMMUNOLOGY

Roles of galectins in infection

(2009) Gerardo R. Vasta   NATURE REVIEWS MICROBIOLOGY

Immunodeficiency-associated lymphomas

(2008) Huy Tran et al.   BLOOD REVIEWS

AP1-Dependent Galectin-1 Expression Delineates Classical Hodgkin and Anaplastic Large Cell Lymphomas from Other Lymphoid Malignancies with Shared Molecular Features

(2008) S. J. Rodig et al.   CLINICAL CANCER RESEARCH

The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype

(2008) M Vockerodt et al.   JOURNAL OF PATHOLOGY

The role of TRAIL death receptors in the treatment of hematological malignancies

(2008) Elizabeth S. Henson et al.   LEUKEMIA & LYMPHOMA